Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Emilien, G
Maloteaux, JM
Seghers, A
and
Charles, G
1998.
Use of a placebo in clinical trials.
European Psychiatry,
Vol. 13,
Issue. 5,
p.
254.
Johnson, Tony
1998.
Clinical trials in psychiatry: background and statistical perspective.
Statistical Methods in Medical Research,
Vol. 7,
Issue. 3,
p.
209.
van den Burg, Willem
1998.
De (in)effectiviteit van psychofarmaca.
Dth,
Vol. 18,
Issue. 1,
p.
1.
Mendlewicz, J
1998.
The broad spectrum of comorbid depression: implications for treatment.
European Psychiatry,
Vol. 13,
Issue. 1,
p.
1.
Lenz, G.
Aigner, M.
and
Bankier, B.
1998.
Spektrum der Zwangsstörungen.
p.
57.
Mendlewicz, J.
1998.
El espectro amplio de la depresión comórbida: implicaciones para el tratamiento.
European psychiatry (Ed. Española),
Vol. 5,
Issue. 6,
p.
352.
Ellingrod, Vicki L.
1998.
Pharmacotherapy of Primary Obsessive‐Compulsive Disorder: Review of the Literature.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 18,
Issue. 5,
p.
936.
Goodman, Wayne K
Ward, Herbert E
and
Murphy, Tanya K
1998.
Biologic Approaches to Treatment-Refractory Obsessive-Compulsive Disorder.
Psychiatric Annals,
Vol. 28,
Issue. 11,
p.
641.
Greist, John H.
and
Jefferson, James W.
1998.
Pharmacotherapy for obessive-compulsive disorder.
British Journal of Psychiatry,
Vol. 173,
Issue. S35,
p.
64.
King, Robert A.
Leonard, Henrietta
and
March, John
1998.
Practice Parameters for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 37,
Issue. 10,
p.
27S.
Bejerot, S.
Ekselius, L.
and
van Knorring, L.
1998.
Comorbidity between obsessive‐compulsive disorder (OCD) and personality disorders.
Acta Psychiatrica Scandinavica,
Vol. 97,
Issue. 6,
p.
398.
Bejerot, S.
Schlette, P.
Ekselius, L.
Adolfsson, R.
and
von Knorring, L.
1998.
Personality disorders and relationship to personality dimensions measured by the Temperament and Character Inventory in patients with obsessive‐compulsive disorder.
Acta Psychiatrica Scandinavica,
Vol. 98,
Issue. 3,
p.
243.
Broocks, Andreas
Pigott, Teresa A
Hill, James L
Stephanie Canter
Grady, Tana A
L'Heureux, Francine
and
Murphy, Dennis L
1998.
Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive–compulsive disorder (OCD): behavioral and biological results.
Psychiatry Research,
Vol. 79,
Issue. 1,
p.
11.
Montgomery, Stuart A
1998.
Implications of the severity of social phobia.
Journal of Affective Disorders,
Vol. 50,
Issue. ,
p.
S17.
Montgomery, Stuart A.
1998.
Psychopharmacology of Obsessive-Compulsive Disorder.
CNS Spectrums,
Vol. 3,
Issue. S1,
p.
33.
Bergqvist, Peter B.F
Bouchard, Claude
and
Blier, Pierre
1999.
Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder.
Biological Psychiatry,
Vol. 45,
Issue. 2,
p.
164.
Ballenger, James C
1999.
Current treatments of the anxiety disorders in adults.
Biological Psychiatry,
Vol. 46,
Issue. 11,
p.
1579.
Schmitz, Margot
1999.
1×1 der Psychopharmaka.
p.
67.
Heydorn, William E
1999.
Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.
Expert Opinion on Investigational Drugs,
Vol. 8,
Issue. 4,
p.
417.
Grados, Marco
Scahill, Lawrence
and
Riddle, Mark A.
1999.
Pharmacotherapyin Children and Adolescents With Obsessive-Compulsive Disorder.
Child and Adolescent Psychiatric Clinics of North America,
Vol. 8,
Issue. 3,
p.
617.
eLetters
No eLetters have been published for this article.